Peter Singer shows why a recipient of a new liver or kidney is not necessarily the only one who benefits.
Source
Related posts
David Llewellyn-Smith is Chief Strategist on the MB Fund and MB Tremendous. David is the founding writer and editor of MacroBusiness and was the founding writer and international financial system editor of The Diplomat, the Asia Pacific’s main geo-politics and... Continue reading
The Australian Bureau of Statistics (ABS) released housing construction data for Q3 2024, again showing that the Albanese government’s target to build 1.2 million homes over five years is delusional. The number of dwellings commencing construction in Q3 2024 rose... Continue reading
Here it is. Over the past two years, the Biden administration struck a careful balance on artificial intelligence. The White House took steps to ensure the US stayed ahead of China in developing the technology while also trying to address... Continue reading
DXY is holding but looks vulnerable to more pullback. AUD the opposite. CNY pumped and dumped on tariff talk. Oil is offering hope to risk. Advertisement All commods had been whacked on Trump’s 10% China tariff menace. Massive miners too.... Continue reading
Wall Street advanced once more although the broader S&P500 just missed out on making a new high with tech stocks again leading the way. European bourses were somewhat mixed on the periphery but also performed well. The USD is now... Continue reading
Add comment